Issued Patents All Time
Showing 1–25 of 125 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12385049 | Modification of RNA, producing an increased transcript stability and translation efficiency | Ugur Sahin, Silke Holtkamp, Sebastian Kreiter | 2025-08-12 |
| 12188097 | Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis | Ugur Sahin, Daniel Maurus | 2025-01-07 |
| 12133899 | Coronavirus vaccine | Ugur Sahin, Alptekin Güler, Andreas Kuhn, Alexander Muik, Annette Vogel +3 more | 2024-11-05 |
| 12059464 | Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer | Ugur Sahin, Rita Mitnacht-Kraus, Stefan Jacobs, Magdalena Jadwiga Utsch, Cornelia Adriana Maria Heinz +1 more | 2024-08-13 |
| 11976130 | Antibodies against claudin 18.2 useful in cancer diagnosis | Ugur Sahin, Rita Mitnacht-Kraus, Stefan Woll | 2024-05-07 |
| 11925694 | Coronavirus vaccine | Ugur Sahin, Alptekin Güler, Andreas Kuhn, Alexander Muik, Annette Vogel +3 more | 2024-03-12 |
| 11919951 | Antibodies useful in cancer diagnosis | Rita Mitnacht-Kraus, Stefan Woll, Korden Walter, Ugur Sahin | 2024-03-05 |
| 11859008 | Antibodies for treatment of cancer expressing claudin 6 | Ugur Sahin, Michael Koslowski, Korden Walter, Stefan Woll, Maria Kreuzberg +3 more | 2024-01-02 |
| 11858988 | Antibodies specific for claudin 6 (CLDN6) | Ugur Sahin, Michael Koslowski, Korden Walter, Stefan Woll, Maria Kreuzberg +2 more | 2024-01-02 |
| 11826402 | Combination therapy involving antibodies against claudin 18.2 for treatment of metastatic pancreatic adenocarcinoma | Ugur Sahin, Rita Mitnacht-Kraus, Stefan Woll, Stefan Jacobs, Cornelia Adriana Maria Heinz | 2023-11-28 |
| 11795218 | Diagnosis and therapy of cancer involving cancer stem cells | Ugur Sahin, Korden Walter, Meike Wagner, Maria Kreuzberg, Sabine Hacker +1 more | 2023-10-24 |
| 11787862 | Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for treatment of Claudin expressing cancer diseases | Ugur Sahin, Christiane Stadler, Leyla Fischer, Arne Jendretzki, Fabrice Le Gall +1 more | 2023-10-17 |
| 11739139 | Monoclonal antibodies against Claudin-18 for treatment of cancer | Ugur Sahin, Dirk Usener, Stefan Fritz, Christoph Uherek, Gunda Brandenburg +3 more | 2023-08-29 |
| 11732308 | Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis | Ugur Sahin, Daniel Maurus | 2023-08-22 |
| 11713346 | Claudin-18.2-specific immunoreceptors and T cell epitopes | Ugur Sahin, Petra OEHM, Tana Omokoko, Andrea BREITKREUZ, Karolina Anna Mroz +1 more | 2023-08-01 |
| 11547673 | Coronavirus vaccine | Ugur Sahin, Alptekin Güler, Andreas Kuhn, Alexander Muik, Annette Vogel +3 more | 2023-01-10 |
| 11541127 | Drug conjugates comprising antibodies against claudin 18.2 | Ugur Sahin, Korden Walter, Maria Kreuzberg, Rita Mitnacht-Kraus, Fabrice Le Gall +1 more | 2023-01-03 |
| 11473085 | Methods and compositions for diagnosis and treatment of cancer | Ugur Sahin, Michael Koslowski, Gerd Helftenbein, Korden Walter, Stefan Woll +1 more | 2022-10-18 |
| 11395852 | Therapy involving antibodies against Claudin 18.2 for treatment of cancer | Ugur Sahin | 2022-07-26 |
| 11345731 | Claudin-6-specific immunoreceptors and t cell epitopes | Ugur Sahin, Petra Simon, Tana Omokoko, Holger Hoff, Ralf-Holger Voss +3 more | 2022-05-31 |
| 11311611 | Antigen-specific T cell receptors and T cell epitopes | Ugur Sahin, Petra Simon, Tana Omokoko | 2022-04-26 |
| 11298426 | Recombinant vaccines and use thereof | Ugur Sahin, Sebastian Kreiter | 2022-04-12 |
| 11279757 | Antibodies useful in cancer diagnosis | Rita Mitnacht-Kraus, Stefan Woll, Korden Walter, Ugur Sahin | 2022-03-22 |
| 10946069 | Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer | Ugur Sahin, Rita Mitnacht-Kraus, Stefan Woll, Stefan Jacobs, Cornelia Adriana Maria Heinz | 2021-03-16 |
| 10927413 | Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis | Ugur Sahin, Daniel Maurus | 2021-02-23 |